MIRM
MIRUM PHARMACEUTICALS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
MIRUM PHARMACEUTICALS INC (MIRM) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$115.52M; the largest are Baker Bros. Advisors, Renaissance Technologies, Izzy Englander. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 3 trimmed, 2 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders42 also report options
Congress trades0
Price$87.54vs quarter-end-25.22%
Sectors0
This quarter's moves
Top holderBaker Bros. AdvisorsNew0
Added0
Trimmed / sold5
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $52.21M0.3% of portfolio445,9752026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Baker Bros. Advisors | $52.21M | 0.3% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $1.07M— of portfolio9,1002026 Q2
Value $901.4K— of portfolio7,7002026 Q2
Value $772.7K— of portfolio6,6002026 Q2
Value $234.1K— of portfolio2,0002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $1.07M | — | — |
| Ken GriffinPUT | $901.4K | — | — |
| Steven CohenPUT | $772.7K | — | — |
| Steven CohenCALL | $234.1K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.